Skip to content

Developmental Epidemiological Study of Children Born Through Reproductive Technology

The Developmental Epidemiological Study of Children Born Through Reproductive Technology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03799107
Acronym
DESCRT
Enrollment
2020
Registered
2019-01-10
Start date
2017-07-14
Completion date
2022-06-30
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Infertility, Female, Infertility, Male, Infertility Primary, Infertility Secondary, Infertility Unexplained

Brief summary

DESCRT will be a long-term study that both looks back in time, at successful pregnancies, and forward in time at early pregnancy and long-term as these children grow. Currently, there are limited data on the long-term effects of infertility and infertility treatments on children. There are some studies to suggest that these children may have altered metabolic profiles, but this study aims to be the largest study to answer this question.

Detailed description

Over the past 30 years, much of the research and clinical effort in the field of ART had to do with improving outcome in terms of successful pregnancy. However, as these rates have increased, attention is slowly turning to focus on the health of the resultant child. Short-term health complications, in particular birth defects,have been well-described. However, even this "hard" outcome has been difficult to characterize as studies used different methodologies, varied age of detection, and frequently didn't have an appropriate comparison group. When underlying parental factors and infertility are included in the analyses, the association is substantially weakened or disappears completely. This exemplifies the problems with much of the currently available research regarding childhood outcomes following ART. While the health of children born through these technologies is of critical public health interest, and of personal interest to families, only limited data exist. In order to evaluate the potential risk to long-term health of children conceived through assisted reproductive technologies (ART) and non-IVF fertility treatments (NIFT), rigorous epidemiological methods, appropriate characterization of the exposure, standardized collection of outcome data, and appropriate comparison groups are required. The proposed Developmental Epidemiological Study of Children born through Reproductive Technology (DESCRT) is aimed to carefully address these important characteristics.

Interventions

None listed

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Retrospective arm Inclusion criteria: \- children conceived by parent(s) who sought evaluation/treatment for infertility

Exclusion criteria

\- Children with chronic medical illnesses that prevent a study visit Prospective arm Inclusion criteria: \- seeking evaluation/treatment for infertility

Design outcomes

Primary

MeasureTime frameDescription
Metabolic testing of child - fasting glucose1 day at study visitFasting glucose mg/dL
Metabolic testing of child - fasting insulin1 day at study visitFasting insulin uIU/mL
Metabolic testing of child - uric acid1 day at study visituric acid mg/dL
Metabolic testing of child - total cholesterol1 day at study visitCholesterol, Total mg/dL
Metabolic testing of child - HDL cholesterol1 day at study visitHDL cholesterol mg/dL
Metabolic testing of child - LDL cholesterol1 day at study visitLDL cholesterol mg/dL
Metabolic testing of child - Triglycerides1 day at study visitTriglycerides mg/dL
Metabolic testing of child - cholesterol ratio1 day at study visitCHOL/HDLC ratio
Metabolic testing of child - non-HDL cholesterol1 day at study visitNon-HDL cholesterol mg/dL
Metabolic testing of child - Alanine Aminotransferase1 day at study visitAlanine Aminotransferase (ALT) U/L

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMarcelle Cedars, MD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026